Mesoporous silica nanoparticles surrounded by a lipid bilayer: Absence of in vitro hemonanotoxicity


Nanomedicine aims at rising innovative tools in order to improve the diagnosis and the therapy of human diseases. The development of robust theranostic nanomaterials displaying treatment efficiency and reduction of detrimental... [ view full abstract ]


  1. Christina Grigorakaki (Luxembourg Institute of Health)
  2. Vincent Schlesser (Centre Hospitalier de Luxembourg)
  3. Céline Hoffmann (Luxembourg Institute of Health)
  4. Jean-Sébastien Thomann (Luxembourg Institute of Science and Technology)
  5. Gaëlle Corne (Luxembourg Institute of Science and Technology)
  6. César Pascual Garcia (Luxembourg Institute of Science and Technology)
  7. Sivashankar Krishnamoorthy (Luxembourg Institute of Science and Technology)
  8. Rolf Bjerkvig (Luxembourg Institute of Health)
  9. Valérie Palissot (Luxembourg Institute of Health)

Topic Area

Toxicology and risk assessment of nanomedicine systems


PS1 » Poster Session & Sponsors Exhibition (13:30 - Wednesday, 28th September, Patio 25)

Presentation Files

The presenter has not uploaded any presentation files.